Citadel Advisors
USNA icon

Citadel Advisors’s Usana Health Sciences USNA Stock Holding History

Citadel Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$719K Sell
41,148
-110,268
-73% -$2.19M ﹤0.01% 8442
2025
Q4 		$2.97M Buy
151,416
+99,419
+191% +$2.06M ﹤0.01% 5182
2025
Q3 		$1.43M Sell
51,997
-114,371
-69% -$3.52M ﹤0.01% 6765
2025
Q2 		$5.08M Buy
166,368
+28,073
+20% +$797K ﹤0.01% 4084
2025
Q1 		$3.73M Buy
138,295
+6,868
+5% +$217K ﹤0.01% 4376
2024
Q4 		$4.72M Buy
131,427
+23,643
+22% +$884K ﹤0.01% 4057
2024
Q3 		$4.09M Buy
107,784
+72,379
+204% +$2.97M ﹤0.01% 4279
2024
Q2 		$1.6M Buy
35,405
+7,460
+27% +$343K ﹤0.01% 5729
2024
Q1 		$1.36M Sell
27,945
-18,331
-40% -$898K ﹤0.01% 6300
2023
Q4 		$2.48M Buy
46,276
+5,633
+14% +$285K ﹤0.01% 4989
2023
Q3 		$2.38M Buy
40,643
+21,996
+118% +$1.38M ﹤0.01% 4900
2023
Q2 		$1.18M Sell
18,647
-21,149
-53% -$1.35M ﹤0.01% 6126
2023
Q1 		$2.5M Buy
39,796
+34,436
+642% +$2.05M ﹤0.01% 4960
2022
Q4 		$285K Sell
5,360
-30,554
-85% -$1.66M ﹤0.01% 9427
2022
Q3 		$2.01M Buy
35,914
+18,291
+104% +$1.21M ﹤0.01% 5569
2022
Q2 		$1.28M Buy
17,623
+6,976
+66% +$520K ﹤0.01% 6467
2022
Q1 		$846K Buy
+10,647
New +$960K ﹤0.01% 8095
2021
Q3 		– Sell
-2,475
Closed -$238K – 14700
2021
Q2 		$253K Sell
2,475
-14,886
-86% -$1.49M ﹤0.01% 11672
2021
Q1 		$1.7M Sell
17,361
-38,037
-69% -$3.46M ﹤0.01% 6800
2020
Q4 		$4.27M Buy
55,398
+8,071
+17% +$624K ﹤0.01% 3940
2020
Q3 		$3.49M Sell
47,327
-37,551
-44% -$3.01M ﹤0.01% 3719
2020
Q2 		$6.23M Buy
84,878
+29,718
+54% +$2.33M ﹤0.01% 2776
2020
Q1 		$3.19M Buy
55,160
+5,272
+11% +$367K ﹤0.01% 3359
2019
Q4 		$3.92M Buy
49,888
+39,579
+384% +$2.92M ﹤0.01% 3405
2019
Q3 		$705K Sell
10,309
-32,874
-76% -$2.21M ﹤0.01% 6184
2019
Q2 		$3.43M Sell
43,183
-121,174
-74% -$9.61M ﹤0.01% 3643
2019
Q1 		$13.8M Buy
164,357
+111,711
+212% +$11.7M 0.01% 1688
2018
Q4 		$6.2M Sell
52,646
-37,238
-41% -$4.31M ﹤0.01% 2492
2018
Q3 		$10.8M Buy
89,884
+79,399
+757% +$9.85M ﹤0.01% 2002
2018
Q2 		$1.21M Buy
+10,485
New +$1.15M ﹤0.01% 4891
2018
Q1 		– Sell
-8,869
Closed -$657K – 8809
2017
Q4 		$657K Sell
8,869
-4,409
-33% -$295K ﹤0.01% 5266
2017
Q3 		$766K Buy
13,278
+9,660
+267% +$571K ﹤0.01% 4697
2017
Q2 		$232K Sell
3,618
-24,750
-87% -$1.53M ﹤0.01% 6342
2017
Q1 		$1.63M Buy
28,368
+23,455
+477% +$1.4M ﹤0.01% 3311
2016
Q4 		$301K Sell
4,913
-22,103
-82% -$1.44M ﹤0.01% 5663
2016
Q3 		$1.87M Buy
27,016
+15,568
+136% +$1.03M ﹤0.01% 3046
2016
Q2 		$638K Buy
+11,448
New +$690K ﹤0.01% 4163
2015
Q4 		– Sell
-49,146
Closed -$3.29M – 9236
2015
Q3 		$3.29M Buy
49,146
+45,650
+1,306% +$3.23M ﹤0.01% 2355
2015
Q2 		$239K Sell
3,496
-27,528
-89% -$1.75M ﹤0.01% 6077
2015
Q1 		$1.72M Buy
31,024
+6,850
+28% +$351K ﹤0.01% 3252
2014
Q4 		$1.24M Buy
+24,174
New +$1.19M ﹤0.01% 3494
2014
Q3 		– Sell
-7,662
Closed -$299K – 8415
2014
Q2 		$299K Sell
7,662
-18,350
-71% -$681K ﹤0.01% 5074
2014
Q1 		$980K Buy
+26,012
New +$909K ﹤0.01% 3453
2013
Q4 		– Sell
-8,930
Closed -$387K – 7180
2013
Q3 		$387K Sell
8,930
-806
-8% -$32.3K ﹤0.01% 4080
2013
Q2 		$352K Buy
+9,736
New +$296K ﹤0.01% 4160

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's USNA Position: Q1 2026 in Review

Citadel Advisors reduced its Usana Health Sciences (USNA) stake by 73% in Q1 2026, selling an estimated $2.19M and leaving 41,148 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #8442.

Citadel Advisors first reported a position in USNA in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.8M in Q1 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Citadel Advisors held 41,148 shares of Usana Health Sciences worth $719K as of Q1 2026.
  • Citadel Advisors sold 110,268 Usana Health Sciences shares in Q1 2026, an estimated $2.19M.
  • Usana Health Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8442 holding.
  • Citadel Advisors first reported a position in Usana Health Sciences in Q2 2013 and has held it in 45 quarters since.
  • Citadel Advisors's Usana Health Sciences position peaked at $13.8M in Q1 2019.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.